EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Synbiotic Supplementation With Heyndrickxia coagulans TBC169 Improves Chronic Constipation in Middle‐Aged and Elderly

Xiaoni Zhou, Canhui Guo, Gang Hu, Leiping Ding, Tingting Zou, Mei Wang, Wenjie Xiong, Wen Deng, Jing Wei, Jiangqing Yu, Chunbo Zhang iD, Huaijun Tu und 1 weitere

Biotechnology Journal · 2026-06 · 21 (6)

DOI: 10.1002/biot.70250 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Biotechnology Journal, online erschienen am 02.06.2026. Verfasst von Xiaoni Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, the Second People's Hospital of Jingdezhen, Jingdezhen, Jiangxi, China. Hauptthemen laut MEDLINE: Constipation, Synbiotics, Zingiberaceae. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Second Affiliated Hospital of Nanchang University Funding Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic constipation is prevalent in middle‐aged and elderly individuals and can markedly impair quality of life and increase comorbidity risk. However, safe and effective therapies for this population remain limited because of age‐related physiological changes, polypharmacy, and concerns about long‐term medication use.

Methods

We conducted a randomized, double‐blind, controlled clinical trial enrolling 140 participants aged ≥45 years with chronic constipation to evaluate a synbiotic containing Heyndrickxia coagulans ( H. coagulans ) TBC169 plus dietary fibers as an adjunct intervention.

Results

Compared with dietary fiber alone, the TBC169‐based synbiotic significantly improved constipation outcomes, including increased weekly bowel movements (WBMs), higher Bristol stool scale (BSS) scores, and reduced Wexner and Patient Assessment of Constipation Quality of Life (PAC‐QOL) scores. Post‐intervention gut microbiota profiling showed higher Shannon and Faith_PD diversity indices and distinct community composition in the synbiotic group compared with the dietary‐fiber control group, along with higher relative abundance of Blautia , Akkermansia , Faecalibacterium , and Bacillus and lower relative abundance of Collinsella . Because baseline faecal samples were not collected, these microbiota findings should be interpreted as exploratory between‐group associations. Ecological analyses suggested enhanced microbial stability and metabolic potential, and correlations linked key taxa with clinical improvement. The intervention was well‐tolerated, with only mild, transient adverse events.

Conclusions

The synbiotic formulation containing H. coagulans TBC169 and dietary fiber‐related components was well‐tolerated and may improve constipation‐related outcomes in middle‐aged and elderly adults. Because the formulation contained both probiotic and fiber components, the observed effects should be attributed to the combined synbiotic product rather than to H. coagulans TBC169 alone. Trial Registration : Chinese Clinical Trial Registry (ChiCTR2400085844, http://www.chictr.org.cn/ ), registered on June 19, 2024.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationSynbioticsZingiberaceaeHumansDouble-Blind MethodMiddle AgedAgedFemaleMaleGastrointestinal MicrobiomeQuality of LifeDietary FiberChronic DiseaseDietary Supplements

Stichwörter der Autor:innen

Heyndrickxia coagulanschronic constipationmiddle‐aged and elderlyrandomized controlled trialsynbiotic

Substanzen

Dietary Fiber

Autor:innen und Institutionen

  • Department of Obstetrics & Gynecology, the Second People's Hospital of Jingdezhen, Jingdezhen, Jiangxi, China.
  • Department of Geriatrics, the Second Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • School of Life Sciences, Nanchang University, Nanchang, Jiangxi, China.
  • National Engineering Research Center for Bioengineering Drugs and the Technologies, Jiangxi Province Key Laboratory of Bioengineering Drugs, Institute of Translational Medicine, Jiangxi Medical College, Nanchang Univers…
  • Jiangxi Province Key Laboratory of Bioengineering Drugs, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Nanchang University Queen Mary School, Nanchang, Jiangxi, China.

ORCID-Profile: Chunbo Zhang, Tingtao Chen

Förderung

  • The Second Affiliated Hospital of Nanchang University Funding Program

Zitieren

APA

Zhou, X., Guo, C., Hu, G., Ding, L., Zou, T., Wang, M., Xiong, W., Deng, W., Wei, J., Yu, J., Zhang, C., Tu, H., & Chen, T. (2026). Synbiotic Supplementation With Heyndrickxia coagulans TBC169 Improves Chronic Constipation in Middle‐Aged and Elderly. Biotechnology Journal, 21(6). https://doi.org/10.1002/biot.70250

Vancouver

Zhou X, Guo C, Hu G, Ding L, Zou T, Wang M, et al. Synbiotic Supplementation With Heyndrickxia coagulans TBC169 Improves Chronic Constipation in Middle‐Aged and Elderly. Biotechnology Journal. 2026;21(6). doi:10.1002/biot.70250

BibTeX
@article{Zhou2026,
  author = {Zhou, Xiaoni and Guo, Canhui and Hu, Gang and Ding, Leiping and Zou, Tingting and Wang, Mei and Xiong, Wenjie and Deng, Wen and Wei, Jing and Yu, Jiangqing and Zhang, Chunbo and Tu, Huaijun and Chen, Tingtao},
  title = {Synbiotic Supplementation With Heyndrickxia coagulans TBC169 Improves Chronic Constipation in Middle‐Aged and Elderly},
  journal = {Biotechnology Journal},
  year = {2026},
  volume = {21},
  number = {6},
  doi = {10.1002/biot.70250}
}
Kostenlos starten →